Cargando…

Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications

Diabetes mellitus (DM) is a metabolic disease, now prevalent worldwide, which is characterized by a relative or absolute lack of insulin secretion leading to chronically increased blood glucose levels. Diabetic patients are often accompanied by multiple macrovascular complications, such as coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jiachao, Hu, Hao, Guo, Rong, Wang, Hui, Jiang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117220/
https://www.ncbi.nlm.nih.gov/pubmed/33995278
http://dx.doi.org/10.3389/fendo.2021.646233
_version_ 1783691551731351552
author Xiong, Jiachao
Hu, Hao
Guo, Rong
Wang, Hui
Jiang, Hua
author_facet Xiong, Jiachao
Hu, Hao
Guo, Rong
Wang, Hui
Jiang, Hua
author_sort Xiong, Jiachao
collection PubMed
description Diabetes mellitus (DM) is a metabolic disease, now prevalent worldwide, which is characterized by a relative or absolute lack of insulin secretion leading to chronically increased blood glucose levels. Diabetic patients are often accompanied by multiple macrovascular complications, such as coronary heart disease, hypertension, macrovascular arteriosclerosis, and microvascular complications. Microvascular complications include diabetic kidney injury, diabetic encephalopathy, and diabetic foot, which reduce the quality of life and survival status of patients. Mesenchymal stem cell exosomes (MSC-Exos) possess repair functions similar to MSCs, low immunogenicity, and ease of storage and transport. MSC-Exos have been proven to possess excellent repair effects in repairing various organ damages. This study reviews the application of MSC-Exos in the treatment of DM and its common complications. MSC-Exos may be used as an effective treatment for DM and its complications.
format Online
Article
Text
id pubmed-8117220
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81172202021-05-14 Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications Xiong, Jiachao Hu, Hao Guo, Rong Wang, Hui Jiang, Hua Front Endocrinol (Lausanne) Endocrinology Diabetes mellitus (DM) is a metabolic disease, now prevalent worldwide, which is characterized by a relative or absolute lack of insulin secretion leading to chronically increased blood glucose levels. Diabetic patients are often accompanied by multiple macrovascular complications, such as coronary heart disease, hypertension, macrovascular arteriosclerosis, and microvascular complications. Microvascular complications include diabetic kidney injury, diabetic encephalopathy, and diabetic foot, which reduce the quality of life and survival status of patients. Mesenchymal stem cell exosomes (MSC-Exos) possess repair functions similar to MSCs, low immunogenicity, and ease of storage and transport. MSC-Exos have been proven to possess excellent repair effects in repairing various organ damages. This study reviews the application of MSC-Exos in the treatment of DM and its common complications. MSC-Exos may be used as an effective treatment for DM and its complications. Frontiers Media S.A. 2021-04-29 /pmc/articles/PMC8117220/ /pubmed/33995278 http://dx.doi.org/10.3389/fendo.2021.646233 Text en Copyright © 2021 Xiong, Hu, Guo, Wang and Jiang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Xiong, Jiachao
Hu, Hao
Guo, Rong
Wang, Hui
Jiang, Hua
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
title Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
title_full Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
title_fullStr Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
title_full_unstemmed Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
title_short Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
title_sort mesenchymal stem cell exosomes as a new strategy for the treatment of diabetes complications
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117220/
https://www.ncbi.nlm.nih.gov/pubmed/33995278
http://dx.doi.org/10.3389/fendo.2021.646233
work_keys_str_mv AT xiongjiachao mesenchymalstemcellexosomesasanewstrategyforthetreatmentofdiabetescomplications
AT huhao mesenchymalstemcellexosomesasanewstrategyforthetreatmentofdiabetescomplications
AT guorong mesenchymalstemcellexosomesasanewstrategyforthetreatmentofdiabetescomplications
AT wanghui mesenchymalstemcellexosomesasanewstrategyforthetreatmentofdiabetescomplications
AT jianghua mesenchymalstemcellexosomesasanewstrategyforthetreatmentofdiabetescomplications